Detalhe da pesquisa
1.
Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2.
Sci Rep
; 14(1): 2038, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263191
2.
Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variants.
Heliyon
; 10(5): e27033, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38486776
3.
Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates.
Nat Commun
; 14(1): 1309, 2023 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36894558
4.
Beta-spike-containing boosters induce robust and functional antibody responses to SARS-CoV-2 in macaques primed with distinct vaccines.
Cell Rep
; 42(11): 113292, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007686
5.
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters.
Commun Med (Lond)
; 3(1): 75, 2023 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237062
6.
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine.
medRxiv
; 2023 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523415
7.
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial.
Lancet Respir Med
; 11(11): 975-990, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37716365
8.
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.
EClinicalMedicine
; 62: 102109, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533419
9.
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.
EClinicalMedicine
; 64: 102168, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936652
10.
Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates.
Nat Commun
; 13(1): 1699, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35361754
11.
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
Lancet Infect Dis
; 22(5): 636-648, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090638
12.
Immunization with a poly (lactide co-glycolide) encapsulated plasmid DNA expressing antigenic regions of HPV 16 and 18 results in an increase in the precursor frequency of T cells that respond to epitopes from HPV 16, 18, 6 and 11.
Cell Immunol
; 270(1): 62-9, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21550027
13.
The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022.
Nat Commun
; 13(1): 5794, 2022 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36184631
14.
Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons.
Vaccine
; 29(47): 8520-9, 2011 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21945262
15.
A heat shock protein based polyvalent vaccine targeting HSV-2: CD4(+) and CD8(+) cellular immunity and protective efficacy.
Vaccine
; 29(47): 8530-41, 2011 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21767588
16.
Microcapillary liquid chromatography/tandem mass spectrometry using alkaline pH mobile phases and positive ion detection.
Rapid Commun Mass Spectrom
; 17(9): 909-16, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12717763
17.
Global proteome analysis of a human gastric carcinoma.
Electrophoresis
; 23(18): 3233-40, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12298095
18.
The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells.
Blood
; 102(9): 3287-94, 2003 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12869499